盐酸缬更昔洛韦片价格

It is the prodrug of ganciclovir, which is quickly converted into ganciclovir after oral administration and is less toxic. Ganciclovir, trade name Vansevir, etc., is an antiviral drug used to treat patients with acquired immunodeficiency syndrome (AIDS) combined with cytomegalovirus (CMV) retinitis, and to prevent CMV infection in high-risk solid organ transplant patients.

How much does Valganciclovir Hydrochloride Tablets cost?

It is reported that valganciclovir hydrochloride tablets are already on the market in China and are relatively expensive. Most patients say they cannot afford it. The domestic valganciclovir hydrochloride tablets are available in 450mg-60 tablets/box and sell for about US$2,250.

Fortunately, Roche's valganciclovir hydrochloride tablets are also available in India, and the price is the lowest in the world. India's Valgancilovir (valganciclovir hydrochloride tablets, valgansiklovir) 450mg*60 tablets/box sells for about US$750. Due to the floating exchange rate, the price is not fixed. Please consult Medical Travel for specific prices.

The Indian version of Valganciclovir Hydrochloride Tablets is currently unavailable in China. Hospitals or pharmacies cannot buy the Indian version of Valganciclovir Hydrochloride Tablets. If patients need it, they can go to Indian pharmacies to buy the medicine in person or ask relatives or friends to bring it back. If the above two methods are not feasible, they can also To purchase genuine Indian Valganciclovir Hydrochloride Tablets through regular and reliable channels, you should choose a professional overseas medical service organization trusted by many patients [such as Medical Companion Travel]. Through this organization, you can directly purchase Indian Valganciclovir Hydrochloride Tablets without leaving home. The safety of the medicine is guaranteed and the cost is transparent. If you need help, please consult the medical companion passenger service.

Induction therapy of CMV retinitis: For patients with active CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) twice daily for 21 days. Prolonged induction therapy may increase the risk of bone marrow toxicity. Maintenance treatment of CMV retinitis: After induction therapy, or in patients with inactive CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) once daily. Induction therapy may be repeated in patients with worsening retinitis. Prevention of CMV infection in transplant patients: For patients who have received solid organ transplants, the recommended dose is 900 mg (two 450 mg tablets) once daily, starting within 10 days after transplantation and continuing until 100 days after transplantation.